Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 14Oropharyngeal Neoplasms 12Lung Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Mouth Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Small Cell Lung Carcinoma 7Uterine Cervical Neoplasms 6Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Nasopharyngeal Carcinoma 6Hypopharyngeal Neoplasms 6Pancreatic Neoplasms 5Mesothelioma, Malignant 5Triple Negative Breast Neoplasms 4Medulloblastoma 4Ganglioneuroblastoma 4Gallbladder Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 3Salivary Gland Neoplasms 3Prostatic Neoplasms 3Neuroblastoma 3Lymphoid Interstitial Pneumonia 3Fallopian Tube Neoplasms 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Adenocarcinoma of Lung 3Testicular Neoplasms 2

Interventions

Paclitaxel 15Carboplatin 9liposomal doxorubicin 8Bevacizumab 8pembrolizumab 7Topotecan 6olaparib 4mirvetuximab soravtansine 4Nivolumab 4Cyclophosphamide 4niraparib 3fludarabine 3Gemcitabine 3Drug Therapy 3rucaparib 2ribociclib 2pegfilgrastim 2palbociclib 2oregovomab 2fludarabine phosphate 2Irinotecan 2Hyperthermic Intraperitoneal Chemotherapy 2Fulvestrant 2Cisplatin 2Blood Specimen Collection 21-dodecylpyridoxal 2trastuzumab deruxtecan 1sacituzumab govitecan 1isoquercitrin 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Platinum × 1 year × Clear all
NCT05763199 2026-03-12

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

University of California, Davis

Phase 2 Active not recruiting
20 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡